Cargando…
Antagonism of Stem Cell Factor/c-kit Signaling Attenuates Neonatal Chronic Hypoxia-Induced Pulmonary Vascular Remodeling
BACKGROUND: Accumulating evidence suggests that c-kit positive cells are present in the remodeled pulmonary vasculature bed of patients with pulmonary hypertension (PH). Whether stem cell factor (SCF)/ c-kit regulated pathways potentiate pulmonary vascular remodeling is unknown. Here, we tested the...
Autores principales: | Young, Karen C, Torres, Eneida, Hehre, Dorothy, Wu, Shu, Suguihara, Cleide, Hare, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837030/ https://www.ncbi.nlm.nih.gov/pubmed/26705118 http://dx.doi.org/10.1038/pr.2015.275 |
Ejemplares similares
-
Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system
por: Camelo, J.S., et al.
Publicado: (2012) -
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
por: Paddenberg, Renate, et al.
Publicado: (2007) -
Effects of FHL1 and P21 on hypoxia-induced pulmonary vascular remodeling in neonatal rats
por: Du, Yanna, et al.
Publicado: (2017) -
Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2021) -
Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2022)